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Purpose: Obesity is one of the most important nutritional disorders in the world which has 
an obvious relationship with the incidence of metabolic diseases. Obesity prevalence has 
increased among children and adolescents during recent decades, leading to a rise in Type 2 
diabetes mellitus (DM II) prevalence in these two age brackets. Hence, the aim of this study 
was to assess impaired glucose tolerance and insulin resistance, and gather metabolic findings 
in obese children and adolescents.
Methods and materials: We studied 110 obese children and adolescents (body mass 
index . 95th percentile for age and gender) 4–18 years of age referred to the endocrine clinic 
of the Children’s Hospital at Tabriz University in a descriptive cross-sectional study.   Fasting 
glucose, insulin, and lipid profile in all subjects were determined. Oral glucose tolerance test 
after eating 75 g/kg glucose was performed. Homeostatic model assessment was used to   estimate 
insulin resistance.
Results: Impaired glucose tolerance and insulin resistance prevalence in 68 obese adolescents 
was 14.7% and 31.8%, respectively. Impaired glucose tolerance and insulin resistance was not 
seen in 23.8% of 42 obese children. No case of DM II was seen. There was a significant statisti-
cal difference in glucose (P = 0.003) and insulin (P , 0.001) level at minute 120 in individuals 
with impaired glucose tolerance compared to obese children and adolescents without impaired 
glucose tolerance. Rate of insulin resistance in patients with impaired glucose tolerance was 
greater and had a significant statistical difference (P = 0.03).
Conclusion: Obesity has a close relationship with increased risk of impaired glucose tolerance 
and insulin resistance in children and adolescents. Oral glucose tolerance test, unlike fasting 
glucose test, is a benefit test to predict impaired glucose tolerance. With prompt identification 
and treatment of obese children with impaired glucose tolerance, we can prevent it from pro-
gression towards DM II.
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Introduction
Prevalence of obesity among children and adolescents has been drastically increas-
ing during the last two decades and age of onset of Type 2 diabetes mellitus (DM II) 
symptoms is depreciating.1,2 Prevalence of obesity in many parts of the world has 
doubled during the last two decades and approximately 22 million children under five 
years are overweight.3 Obesity increases the risk of insulin resistance in childhood 
and mortality due to cardiovascular diseases in adulthood.4 Several factors including 
obesity, dyslipidemia, and hypertension in children and adolescents have a significant 
role in elevating the risk of insulin resistance.5Therapeutics and Clinical Risk Management 2010:6 submit your manuscript | www.dovepress.com
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Progressing from glucose tolerance into DM II in 
  adulthood usually has a mediating phase which occurs by 
an alteration in metabolism of glucose and is declared as 
impaired glucose tolerance or the phase before diabetes.6,7
High prevalence of impaired glucose tolerance among 
obese children and adolescents has been reported in many 
descriptive cross-sectional studies, indicating the correlation 
between obesity and severe resistance to insulin, impaired 
glucose tolerance, dysfunction of pancreatic β-cells and 
change of abdominal fat distribution.8
Obesity prevalence in Iran has also been increasing during 
recent decades; in adolescents aged 11–17 years, 22.5% had 
a body mass index (BMI) in 95th percentile and 26.6% were 
suffering from metabolic syndrome.9 Also, many Iranian 
children are suffering from synchronous metabolic syndrome 
as shown in one study where 42.5% of obese children had 
synchronous metabolic syndrome.10
Obesity and insulin resistance play a crucial role in 
pathogenesis of metabolic syndrome.
According to increasing prevalence of obesity and its 
complications in children and adolescents, our aim is to 
determine the prevalence of impaired glucose tolerance and 
insulin resistance among obese children and adolescents.
Methods
In a retrospective randomized study, 110 children and adoles-
cents who were referred for medical assessment of obesity in 
a pediatric endocrinology clinic were studied from June 2006 
through to September 2008. Inclusion criteria were those 
aged 4–18 years with a body mass index (BMI) exceeding 
the 95th percentile for their age and sex. Individuals who 
were receiving drugs which could influence carbohydrate and 
lipid metabolisms, or suffering from diabetes and/or familial 
hyperlipidemia were excluded from the study.
Clinical examination, blood pressure, height (by a wall 
tape measure with accuracy of 0.1 cm) and weight (by a 
SECA weighing machine [SECA Medical, Massachusetts, 
USA] with accuracy of 0.5kg) measurements, and BMI 
(kg/m²) were obtained after receiving informed and written 
consent from parents involved. Fasting blood sampling was 
executed after a 12 hr fasting period to measure glucose, 
insulin, and lipid profile.
We assessed impaired glucose tolerance after eating 
75 g/kg up to a maximum of 750 g glucose in 250 cc water 
and measured blood glucose and insulin level at min 0, 30, 
60, and 120. Glucose was measured by the glucose oxidase 
method and insulin was measured with a radioimmuno-
assay. Insulin resistance rate using homeostasis model 
assessment (HOMA) index was calculated by the following 
formula: HOMA index = [fasting insulin (mU/mL) ×   fasting 
  glucose (mmol/L)]/22.5.11 Lower HOMA index values 
(,4) indicated higher insulin sensitivity, whereas higher 
values (.4) indicated lower insulin sensitivity. Impaired 
glucose tolerance was defined as 2 hr plasma glucose level 
of 140–200 mg/dL. DM II was defined as a fasting glucose 
level over 126 mg/dL or 2 hr postprandial glucose over 
200 mg/dL.12
statistical methods
Statistical analysis was done using the statistical package 
SPSS 16 (IBM, New York, USA). The data is shown as 
Mean ± SD with 95% confidence interval. Normality of 
the distribution was checked for each variable (one sample 
Kolmogorov–Smirnov test). Mann–Whitney U statistical 
was used to check the difference in means of laboratory 
findings between the two groups including adolescents with 
and without insulin resistance. Repeat measure test was used 
for means of glucose and insulin changes at different times. 
Chi-square and Fisher’s exact test were used to determine 
statistical difference in qualitative variables. Association 
between two variables was determined by Pearson corre-
lation. P value less than 0.05 was considered statistically 
significant.
Results
Of the 110 obese children and adolescents conducted in 
this study, 69 were female and 41 were male. The mean age 
was 10.9 ± 3 years; 42 (38.2%) were under 10 years and 68 
(61.8%) were over 10 years. Total impaired glucose tolerance 
prevalence rate was 14.7% in adolescents, which was not seen 
among children, and total prevalence of insulin resistance was 
31.8% in adolescents and 23.8% in children. There was no 
significant difference in the prevalence of impaired glucose 
tolerance between male and female adolescents (8.7% female 
and 9.8% male). Similarly, there was no significant differ-
ence in insulin resistance between males and females (36.7%, 
26.1%). DM II was not seen among obese children and 
adolescents. Table 1 indicates the characteristics of patients 
studied in this study based upon age classification.
There was no significant difference between children 
and adolescents, with and without impaired glucose toler-
ance, at min 0; however, there was a significant statistical 
difference in glucose level (101.9 ± 17.2 mg/dL versus 
145.5 ± 25 mg/dL) and insulin level (62.02 ± 69.7 ng/dL 
versus 208.3 ± 262 ng/dL) at min 120 between the two groups 
(P = 0.003, P , 0.001).Therapeutics and Clinical Risk Management 2010:6 submit your manuscript | www.dovepress.com
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Table 2 shows the measured and metabolic laboratorial 
indices in obese adolescents. According to this table, plasma 
level of very-low-density lipoprotein (VLDL) was signifi-
cantly different between the two groups of adolescents. In 
the other lipid profile, there was no significant difference. 
There were 66 insulin resistant individuals (60%) and HOMA 
index values for these cases were over four, which had a 
significant statistical difference with other obese children 
and adolescents (P = 0.03).
Assessment of glucose and insulin change spectrum at 
different times (Figures 1 and 2) shows a significant differ-
ence in patients with impaired glucose tolerance detected by 
glucose tolerance test (P , 0.001). Among individuals resis-
tant to insulin (n = 31) there was a significant relationship in 
VLDL levels (P = 0.008 and r = −0.4) and triglyceride levels 
(P = 0.01 and r = 0.4). There was not a significant correlation 
between systolic and diastolic blood pressure and resistance 
to insulin based upon HOMA indices.
Discussion
Obesity, together with environmental and genetic factors, 
leads to progression of insulin resistance phase to DM II and 
failure of pancreatic β-cells.13 Obese children and adolescents 
with impaired glucose tolerance are predisposed to being 
high risk for DM II in the future after undergoing a mediating 
period, and oral glucose tolerance test can be a predictor for 
impaired glucose tolerance.14
In one study there was a close relationship in 18% of 
obese Spanish children suffering from metabolic syndrome 
with insulin resistance rate.15 In another study, a high preva-
lence of impaired glucose tolerance was seen among obese 
children and adolescents −25% of obese children aged 4–10 
years and 11% of adolescents over 11 years.6 In a study 
conducted by Viner et al 11% of obese children and adoles-
cents had impaired glucose tolerance, and DM II was a rare 
condition.16 A study by Gallardo et al revealed a carbohydrate 
metabolism disorder in 3.8% of obese children and fasting 
glucose level in most of these individuals, though impaired 
glucose tolerance was normal. Hence, this measurement was 
not useful for screening of patients.17
A study by Tresaco et al estimated that the prevalence 
of impaired glucose tolerance among obese children and 
adolescents had a meaningful difference with other patients.18 
Similarly in our study, prevalence of impaired glucose toler-
ance among obese children and adolescents was outstanding 
and fasting glucose levels in patients did not have meaningful 
difference, but min 120 glucose level was useful in the diag-
nosis of children and adolescents with carbohydrate metabo-
lism disorders. There is a direct relationship between insulin 
resistance and DM II in obese children and adolescents.12
Insulin resistance prevalence, based upon descriptive 
studies, is higher in patients with impaired glucose toler-
ance compared to other children and adolescents in the 
same age group. Insulin resistance incidence may have a 
relationship with obesity like that seen in adults, and central 
obesity is a determinant for hyperinsulinemia.19 Although 
there is a meaningful difference between obese individuals 
with impaired glucose tolerance and others based upon the 
Table 2 Metabolic and laboratory indices measured in obese adolescents (mean ± sD)
Variables  Without insulin 
resistance
With insulin 
resistance
P-value
Glucose level min 0 (mg/dL)  115.5 ± 31.6 136.94 ± 39.9 0.6
Glucose level min 120 (mg/dL) 105.05 ± 22.3 150.5 ± 25 0.002
insulin level in min 0 (ng/dL) 10.6 ± 3.8 25.6 ± 8.9 0.6
insulin level in min 120 (ng/dL) 50.2 ± 51.8 179.9 ± 138.6 ,0.001
Triglyceride (mg/dL) 124.5 ± 68.7 156.2 ± 119.5 0.1
Cholesterol (mg/dL) 178.7 ± 31.9 179.4 ± 34.2 0.5
LDL (mg/dL) 110.5 ± 31.3 109.2 ± 48.6 0.9
VLDL (mg/dL) 20.8 ± 12.5 29.4 ± 24.2 0.03
hDL (mg/dL) 43.01 ± 9.2 48.14 ± 19.7 0.1
systolic blood pressure (mmhg) 111.09 ± 25.5 115.4 ± 25.6 0.5
Diastolic blood pressure (mmhg) 72.7 ± 15.7 68.5 ± 9.4 0.9
Table  1  Characteristics  of  patients  studied,  based  upon  age 
classification
Variables  Children (n = 42)  Adolescents (n = 68)
Gender 
Male 
Female
8 (19%) 
34 (81%)
33 (48.5%) 
35 (51.5%)
Resistance to insulin 
(hOMA . 4)
10 (23.8%) 21 (31.8%)
impaired glucose 
tolerance
– 10 (14.7%)Therapeutics and Clinical Risk Management 2010:6 submit your manuscript | www.dovepress.com
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Tresaco et al study with HOMA indices over four, which is 
an indicator for insulin resistance, there is not any difference 
in triglyceride and lipid profile among them.18 Similarly in 
the Moreira et al study, it has been shown that insulin and 
body fat are very sensitive and specific in predicting insulin 
resistance among obese children and adolescents.11
Our study indicated a high incidence of insulin resis-
tance among obese children and adolescents with impaired 
glucose tolerance. Based on our study, the prevalence of 
obesity among children was higher in females than males, 
but prevalence of obesity in adolescents was very similar 
between the two. This finding is similar to other pediatric 
studies.12 Prevalence of impaired glucose tolerance and 
insulin resistance between male and female children and 
adolescents are similar. In the study by Caceres et al insulin 
resistance was very common among children and adolescents 
with obesity.20 In our study, as in the Tresaco et al study, lipid 
profile abnormalities in individuals with insulin resistance 
is similar to other adolescents with obesity, but only plasma 
level of VLDL was significantly more than adolescents 
without insulin resistance.18 Despite the fact that there was 
a negative meaningful correlation between triglyceride level 
and systolic blood pressure with insulin resistance rate in the 
Wiegand et al study based on HOMA indices,21 our study 
revealed a negative correlation for triglyceride and VLDL 
with HOMA indices.
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Figure 1 Glucose response during oral glucose tolerance test in obese children and adolescents.
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Figure 2 insulin response during oral glucose tolerance test in obese children and adolescents.Therapeutics and Clinical Risk Management
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Conclusion
Obesity has a close relationship with increased risk of 
impaired glucose tolerance and insulin resistance in children 
and adolescents. Oral glucose tolerance test, unlike fasting 
glucose test, is a benefit test to predict impaired glucose 
tolerance. With prompt identification and treatment of obese 
children with impaired glucose tolerance, we can prevent it 
from progression towards DM II.
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